SFPT - Société Française de Pharmacologie et de Thérapeutique

THERAPIES - NUMERO 2 - MARS AVRIL 2019

Le numéro 2 (mars avril 2019) est en ligne

Consultez-le en suivant le lien

https://www.em-consulte.com/revue/THERAP/74/2/table-des-matieres/

NUMERO SPECIAL :  PHARMACOEPIDEMIOLOGY

 

Pharmacoepidemiology, the new paradigm of drug evaluation

Bernard Bégaud, Jean-Louis Montastruc

What is pharmacoepidemiology? Definition, methods, interest and clinical application

Jean-Louis Montastruc, Justine Benevent, François Montastruc, Haleh Bagheri, Fabien Despas, Maryse Lapeyre-Mestre, Agnès Sommet

A history of pharmacoepidemiology

Bernard Bégaud

The limitations of observation studies for decision making regarding drugs efficacy and safety

François Gueyffier, Michel Cucherat

Methods in pharmacoepidemiology

Agnès Sommet, Antoine Pariente

The systematic case-referent method

Lamiae Grimaldi-Bensouda, Lucien Abenhaim

Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs

Maryse Lapeyre-Mestre, François Montastruc

French administrative health care database (SNDS): The value of its enrichment

Lucie-Marie Scailteux, Catherine Droitcourt, Frédéric Balusson, Emmanuel Nowak, Sandrine Kerbrat, Alain Dupuy, Erwan Drezen, André Happe, Emmanuel Oger

Case–non-case studies: Principle, methods, bias and interpretation

Jean-Luc Faillie

Interest of pharmacoepidemiology for the study of inhaled drugs

Mathieu Molimard, Pierre-Olivier Girodet, Eric Van Ganse

Interest of pharmacoepidemiology for the study of psychotropic drugs

M. Tournier, F. Montastruc

Interest of pharmacoepidemiology for the study of anticoagulants

Haleh Bagheri

Interest of pharmacoepidemiology for the study of antibiotic drugs

Agnès Sommet

Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes

Francesco Salvo, Jean-Luc Faillie

Pharmacoepidemiology of statins

Julien Bezin, Nicholas Moore

Pharmacoepidemiology of non-steroidal anti-inflammatory drugs

Nicholas Moore, Mai Duong, Sinem Ezgi Gulmez, Patrick Blin, Cecile Droz

The value of a health insurance database to conduct pharmacoepidemiological studies in oncology

Cécile Conte, Charlotte Vaysse, Pauline Bosco, Pernelle Noize, Annie Fourrier-Reglat, Fabien Despas, Maryse Lapeyre-Mestre

Pharmacoepidemiology in pregnancy

Justine Benevent, Mélanie Araujo, Caroline Hurault-Delarue, Jean-Louis Montastruc, Agnès Sommet, Isabelle Lacroix, Christine Damase-Michel

Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity

Malak Abou Taam, Claire Ferard, Pauline Rocle, Patrick Maison

Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution

Mathilde Dupui, Joëlle Micallef, Maryse Lapeyre-Mestre

Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics

Florentia Kaguelidou, Geneviève Durrieu, Antonio Clavenna

Pharmacoepidemiology in older people: Purposes and future directions

Marie-Laure Laroche, Caroline Sirois, Emily Reeve, Danijela Gnjidic, Lucas Morin

©SFPT 2007-2019

CB Login